ANZCA Pholcodine Statement September 2023
This statement has been prepared in response to the decision of the Australian Government
Therapeutic Goods Administration (TGA) to withdraw pholcodine-containing products from the market. Evidence shows that pholcodine consumption in the 12-month period prior to a general an...
ANZCA letter to Medical Board of Australia Chair Dr Anne Tonkin 20211201
ANZCA's letter to Medical Board of Australia Chair Dr Anne Tonkin re: the Ahpra cosmetic surgery review 1 December 2021
ROSI presentation slides
ROSI branded PowerPoint slide deck that introduces the importance of and reasons for commencing an opioid analgesic stewardship program.
ANZCA response to ACI perioperative toolkit consultation
College feedback to the Agency for Clinical Innovation’s (ACI) perioperative toolkit.
Blue book submission EOI form
Blue book submission expression of interest form
Neuraxial device advice for practitioners
Advice for anaesthetists and pain medicine practitioners on the introduction of neural/neuraxial devices with connectors compliant with the new international standard ISO 80369-6.
SAU_Neuraxial-detailed-info_20190819
PS11(PM) Procedures in Pain Medicine
The Procedures in Pain Medicine Clinical Care Standard provides guidance on what is considered to the appropriate and safe use of procedures and in the practice of pain medicine.
PG58(A)BP Guideline on quality assurance and quality improvement in anaesthesia Background Paper
This document provides background to ANZCA guideline on quality assurance and quality improvement
Anaesthesia for eye surgery
Eye surgery can be performed under eye block, topical anaesthesia or general anaesthesia.
Find out more